Results 101 to 110 of about 693 (177)

EXTRA-PC: a phase II trial of masofaniten (EPI-7386) and enzalutamide for patients with treatment-naïve metastatic hormone-sensitive prostate cancer. [PDF]

Oncologist
Jang A, Fowler P, Helminiak K, Kumar HLS, Pasucal J, Delong V, Zhong JY, Jindal T, Grier AL, Patel RR, Hislop M, Cesano A, Villaluna K, Younginger B, Wolff K, Richey K, Bray J, Garcia H, Adamowicz T, Reese A, Nizam A, Gupta S, Wee CE, Margevicius S, Fu P, Mendiratta P, Sheng IY, Brown JR, Garcia JA, Barata PC.   +29 more
europepmc   +1 more source

Deep learning methods for protein function prediction. [PDF]

Proteomics
Boadu F, Lee A, Cheng J.
europepmc   +1 more source

Magnetic activities of two contact binaries in quadruple stellar systems. [PDF]

Sci Rep
Yang Y, Wang S.
europepmc   +1 more source

JWST interferometric imaging reveals the dusty torus obscuring the supermassive black hole of Circinus galaxy. [PDF]

Nat Commun
Lopez-Rodriguez E, Sanchez-Bermudez J, González-Martín O, Nikutta R, Lau RM, Thatte D, García-Bernete I, Girard JH, Hankins MJ.   +8 more
europepmc   +1 more source

A direct black-hole mass measurement in a little red dot at high redshift. [PDF]

Nature
Juodžbalis I, Marconcini C, D'Eugenio F, Maiolino R, Marconi A, Übler H, Scholtz J, Ji X, Jones GC, Perna M, Arribas S, Bennett JS, Bromm V, Bunker AJ, Carniani S, Charlot S, Cresci G, Dayal P, Egami E, Fabian A, Inayoshi K, Isobe Y, Ivey LR, Koudmani S, Laporte N, Liu B, Lyu J, Mazzolari G, Monty S, Parlanti E, Pérez-González PG, Robertson B, Schneider R, Sijacki D, Tacchella S, Trinca A, Valiante R, Volonteri M, Witstok J, Zhang S.   +39 more
europepmc   +1 more source

Efficacy of Immune Checkpoint Blockade in Advanced Upper Tract Urothelial Cancer With DNA Mismatch Repair Deficiency or Microsatellite Instability. [PDF]

JCO Precis Oncol
Moussa MJ, Andreev-Drakhlin AY, Venkatesan AM, Matin SF, Xiao L, Tidwell RSS, Shah AY, Adriazola AC, Shaw L, Gao J, Lin JK, Goswami S, Msaouel P, Guo CC, Tannir NM, Siefker-Radtke AO, Alhalabi O, Campbell MT.   +17 more
europepmc   +1 more source

Nivolumab plus gemcitabine-cisplatin for unresectable or metastatic urothelial carcinoma: health-related quality-of-life analyses from the phase III CheckMate 901 trial. [PDF]

ESMO Open
Bedke J, van der Heijden MS, Sonpavde G, Galsky MD, Liao W, Shi L, Blum SI, Mitra S, Patel MY, Powles T.   +9 more
europepmc   +1 more source

Avelumab maintenance treatment for advanced urothelial cancer: plain language summary of long-term results from the JAVELIN Bladder 100 study. [PDF]

Future Oncol
Powles T, Park SH, Gurney H, Loriot Y, Sridhar SS, Bellmunt J, di Pietro A, Grivas P.   +7 more
europepmc   +1 more source

SGNDV-001: disitamab vedotin with pembrolizumab in HER2-expressing locally advanced or metastatic urothelial carcinoma. [PDF]

Future Oncol
Powles TB, Grande E, Alimohamed N, Oliveira N, Sridhar SS, Drakaki A, Kanesvaran R, Loriot Y, Necchi A, Franco S, Jiang D, Apolinario K, Zhang W, Galsky MD.   +13 more
europepmc   +1 more source

Cancer Patient Perspectives on Clinical Trial Discussion and Informed Consent Through Telemedicine. [PDF]

JCO Oncol Pract
Khadem Charvadeh Y, Doshi SD, Seier K, Bange EM, Daly B, Lipitz-Snyderman A, Polubriaginof FCG, Buckley M, Kuperman G, Stetson PD, Schrag D, Morris MJ, Panageas KS.   +12 more
europepmc   +1 more source